娛樂城 announces definitive agreement to acquire Vertos Medical, Inc., expanding interventional pain management solutions
22-Aug-2024
PORTAGE, Mich. 鈥 Aug. 22, 2024 鈥 娛樂城 (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire Vertos Medical Inc., a privately held company providing a minimally invasive solution for treating chronic lower back pain caused by lumbar spinal stenosis.
Lumbar spinal stenosis affects millions of people globally and is a leading cause of pain and disability. Patients today are seeking minimally invasive treatment options, valuing reduced recovery times and quicker returns to daily life. Vertos Medical鈥檚 mild庐 procedure provides a solution for pain relief and may improve mobility1,2 without the need for major surgery.
鈥淲e are committed to helping customers restore patients鈥 quality of life with interventional solutions to address chronic pain,鈥 said Andy Pierce, Group President, MedSurg and Neurotechnology, 娛樂城. 鈥淭his acquisition strengthens our minimally invasive pain management portfolio with differentiated treatments and expands our reach across ambulatory surgery centers.鈥
鈥淎llowing patients to get back to what matters most to them is what matters most to us,鈥 said Eric Wichems, Vertos Medical鈥檚 Chief Executive Officer. 鈥湂蕵烦氢檚 mission and focus on interventional solutions provides an opportunity to further improve patients' quality of life.鈥
This transaction is subject to customary closing conditions. 娛樂城 and Vertos Medical Inc. will continue to operate as separate entities and proceed with business as usual until the transaction closes.
娛樂城 娛樂城
娛樂城 is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, 娛樂城 impacts more than 150 million patients annually. More information is available at www.stryker.com.
Media contact
Beth Sizemore
Sr. Director, Strategic Communications
beth.sizemore@stryker.com
References
1. Deer TR, Chafin TB, Costandi SJ, Qu H, Kim C, Jassal N, Patel K, Calodney A. The MOTION study: Two-year results of a real-world randomized controlled trial of the mild庐 procedure for treatment of lumbar spinal stenosis. Pain Pract. 2024 Jan;24(1):109-119.
2. Deer TR, Costandi SJ, Washabaugh E, Chafin TB, Wahezi SE, Jassal N, Sayed D. The MOTION鈥係tudy: A Randomized Controlled Trial with Objective Real-World Outcomes for Lumbar Spinal Stenosis Patients Treated with the mild庐 Procedure: One-Year Results. Pain Med. 2022 Apr 8;23(4):625-634.